Dr Shadman on Indirect Data for Zanubrutinib vs Acalabrutinib/Venetoclax in Treatment-Naive CLL | OncLive
Dr Shadman on Indirect Data for Zanubrutinib vs Acalabrutinib/Ven…
3 weeks ago
onclive.com
Pirtobrutinib Dominates in CLL Trial, Beating Standard Regimen | Blood Cancers Today
Pirtobrutinib Dominates in CLL Trial, Beating Standard Regimen | Bloo…
3 days ago
bloodcancerstoday.com
VIDEO: Pirtobrutinib promising as monotherapy, part of combination regimens in CLL
VIDEO: Pirtobrutinib promising as monotherapy, part of combinatio…
4 months ago
healio.com
Dr Lamanna on the FDA Approval of Acalabrutinib Plus Venetoclax for CLL | OncLive
Dr Lamanna on the FDA Approval of Acalabrutinib Plus Venetoclax for …
1 month ago
onclive.com
ASH 2025 Insights: Late Breaking Abstract - Pirtobrutinib vs. BendaR in Patients With CLL/SLL: 1st Results From a Randomized Phase III Study Examining a ncBTK Inhibitor in Untreated Patients
ASH 2025 Insights: Late Breaking Abstract - Pirtobrutinib vs. Benda…
4 months ago
vumedi.com
Dr Kittai on an Indirect Comparison of Acalabrutinib Plus Obinutuzumab vs Zanubrutinib in CLL/SLL | OncLive
Dr Kittai on an Indirect Comparison of Acalabrutinib Plus Obinutuzum…
Oct 11, 2023
onclive.com
Comparing Ibrutinib, Acalabrutinib, and Zanubrutinib BTKi | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Comparing Ibrutinib, Acalabrutinib, and Zanubrutinib BTKi | Targeted …
Oct 4, 2021
targetedonc.com
1:30
Dr Munir on the Efficacy of First-Line Zanubrutinib vs Acalabrutini…
10 months ago
onclive.com
Dr. Jacobs on the Efficacy of Ibrutinib and Acalabrutinib in Pati…
May 9, 2018
onclive.com
Dr. Mato on Ibrutinib Versus Acalabrutinib in CLL | OncLive
Nov 23, 2019
onclive.com
Pirtobrutinib in R/R B-Cell Malignancies: Newest Data From t…
Dec 15, 2024
vumedi.com
Experts Review Pirtobrutinib Clinical Data and Share its Utilizati…
Aug 15, 2024
onclive.com
Significant Efficacy Benefit Of IMBRUVICA Plus Venetoclax Vers…
10 months ago
marketscreener.com
Dr. Woyach on the Safety of Acalabrutinib Versus Ibrutinib in C…
Sep 11, 2020
onclive.com
Indirect Comparison of Efficacy of Zanubrutinib Versus Acalabrutini…
Jul 5, 2024
onclive.com
Clinical Practice Insights: Comparing the Safety Profiles of …
8 months ago
onclive.com
Comparative Efficacy of Zanubrutinib vs Fixed-Duration Ac…
9 months ago
onclive.com
15:38
Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of …
10 months ago
onclive.com
Dr O’Brien on the Use of Pirtobrutinib in BTK Inhibitor-Resi…
Jun 30, 2023
onclive.com
Rapid Readout: Pirtobrutinib, A Highly Selective, Noncovalent (Re…
Jan 14, 2022
onclive.com
4:04
2026 CLL Update: Game Changer Therapies for Oncologists?
181 views2 months ago
YouTubeOncologyTube
1:26
Rituximab vs. standard chemotherapy: which treatment b…
11.6K viewsMar 8, 2018
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:18
Pirtobrutinib: The next generation of BTK inhibitors
1.5K viewsJun 16, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:46
Overview of Bruton's tyrosine kinase (BTK) inhibitors in chronic …
2.2K viewsFeb 12, 2016
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:18
How CALQUENCE® (acalabrutinib) Works
16.3K viewsOct 1, 2024
YouTubeCALQUENCE (acalabrutinib)
1:16
How to pronounce zanubrutinib
2K viewsAug 21, 2021
YouTubeBiomedical Pronunciation Guide
1:31
How to pronounce acalabrutinib
1.2K viewsAug 21, 2021
YouTubeBiomedical Pronunciation Guide
1:19
How to pronounce ibrutinib
746 viewsAug 21, 2021
YouTubeBiomedical Pronunciation Guide
5:44
Acalabrutinib Versus Ibrutinib for CLL
2K viewsMay 8, 2020
YouTubeTargeted Oncology
1:12
Pirtobrutinib vs nemtabrutinib in CLL
922 viewsNov 2, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder